PHARMAZEUTISCHE COMPOUNDIERUNGSVERFAHREN UND -SYSTEME
European patent · EP4549008 · In force
Register entry
- Publication number
- EP4549008
- Application number
- EP24207480
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 10, 2017
- Published
- May 7, 2025
- Granted
- Oct 14, 2026
- Protection ends at the latest
- Nov 9, 2037
- Next annual fee due
- Nov 30, 2026
- IPC classes
- B01F 29/10 (2022.01)B01F 35/22 (2022.01)B01F 35/42 (2022.01)A61K 9/06 (2006.01)A61K 9/10 (2006.01)A61K 9/107 (2006.01)A61K 9/14 (2006.01)A61K 31/045 (2006.01)A61K 31/4458 (2006.01)A61K 31/57 (2006.01)A61K 31/7048 (2006.01)A61K 33/14 (2006.01)A61K 47/10 (2017.01)A61K 47/26 (2006.01)A61K 47/38 (2006.01)A61K 47/42 (2017.01)A61J 3/04 (2006.01)
- Priority
- US 201662420426 P 10.11.2016
- Divided from
- EP22192358
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 14, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 14.10.2026
Parties
Inventor
DANOPOULOS, Panagiota
Montreal, H2R 2Y1, CA
JOINER, Marc
Saint-Laurent, H4R 3A6, CA
NYAT PENG WONG, Sarah
Saint-Laurent, H4R 3A6, CA
TALEBI, Vargha
Saint-Laurent, H4R 3A6, CA
BADER, Patrick-Martin
Saint-Laurent, H4R 3A6, CA
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.